APP and Alzheimer disease: While signal transducer and activator of transcription 3 (STAT3) are activated in an AD mouse model and human AD, targeted deletion of astrocytic STAT3 in APP/PS1 mice resulted in reduced Aβ and plaque burden (Reichenbach et al., 2019).